# Intensive Cancer Screening After Cryptogenic Stroke

> **NCT05733416** · NA · RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 45 (estimated)

## Conditions studied

- Occult Cancer

## Interventions

- **DIAGNOSTIC_TEST:** FDG PET/CT
- **DIAGNOSTIC_TEST:** Usual Care

## Key facts

- **NCT ID:** NCT05733416
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05733416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05733416, "Intensive Cancer Screening After Cryptogenic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05733416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*